Global Peripheral Arterial Disease (PAD) Market, By Treatment Type (Devices, Catheters, Drugs and Others), Route of Administration (Oral, Parenteral and Others), End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)-Industry Trends and Forecast to 2029
Market Analysis and Size
According to the Surveys, about 6.5 million people age 40 and older in the U.S. have PAD. Both woman and men are affected by PAD; but, African Americans have an increased risk of PAD. The ageing population, which leads to an increase in the prevalence of peripheral artery disease, as well as an increase in product approvals, are all variables that raise the risk of developing peripheral arterial disease (PAD).
Data Bridge Market Research analyses that the peripheral arterial disease (PAD) market was valued at USD 3.82 billion in 2021 and is further estimated to reach USD 7.61 billion by 2029, and is expected to grow at a CAGR of 9% during the forecast period of 2022 to 2029.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment Type (Devices, Catheters, Drugs and Others), Route of Administration (Oral, Parenteral and Others), End Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Bayer AG (Germany), Abbott (US), Boston Scientific Corporation (US), BIOTRONIK (Germany), Cardinal Health (US), Terumo Corporation (Japan), AngioDynamics (US), Koninklijke Philips NV (Netherlands), Cook (US), Medtronic (Ireland), Cardinal Health (US) B. Braun Melsungen AG (Germany),
|
|
Market Opportunities
|
|
Market Definition
Peripheral arterial disease (PAD) is a common cardiovascular condition that is caused by plaque build-up in the arteries, resulting in restricted blood flow to the limbs. Peripheral artery disease is also linked to diabetes, ageing, and high blood pressure.
Peripheral Arterial Disease (PAD) Market Dynamics
Drivers
Major factors that are expected to boost the growth of the peripheral arterial disease (PAD) market in the forecast period are as follows:
- Rise in the elderly population
The rise in the number of geriatrics with diabetes and high blood pressure is a major risk factor for peripheral artery disease, which is fuelling the market.
- Growing demand for minimally-invasive procedures
The growing need for minimally invasive procedures, particularly in the treatment of peripheral artery disease which will further accelerate the market growth.
- Initiatives by the governments
Authorities and governments are taking more measures to improve healthcare systems and raise knowledge about the benefits of PAD devices which will further contribute to the growth of the market.
Opportunities
In addition, the rise in the in prevalence of peripheral artery diseases and growing inproduct approvals is further estimated to provide potential opportunities for the growth of the peripheral arterial disease (PAD) market in the coming years.
Restraints/Challenges
On the other hand, the reoccurrence of peripheral artery disease even after the treatment is further projected to impede the growth of the peripheral arterial disease (PAD) market in the targeted period. However, the product recalls might further challenge the growth of the peripheral arterial disease (PAD) market in the near future.
This peripheral arterial disease (PAD) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the peripheral arterial disease (PAD) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Peripheral Arterial Disease (PAD) Market
The pandemic of COVID-19 has had a huge impact on the peripheral arterial disease (PAD) market. The COVID-19 pandemic had a detrimental impact on the healthcare sector, as most hospitals, clinics, and laboratories were forced to close due to lockdowns and quarantine regulations in many regions of the world. As a result, all non-essential medical procedures were postponed, and the number of outpatient cases decreased significantly during this time. However, in the post-COVID scenario, peripheral arterial disease (PAD) market is projected to be significantly impacted.
Recent Development
In June 2020, Straub Medical AG, a private corporation, was acquired by Becton, Dickinson and Company. Medical atherectomy and thrombectomy devices are developed by Straub Medical AG for the treatment of venous and peripheral arterial disorders (PAD). Becton, Dickinson and Company's peripheral artery disease treatment capabilities have been strengthened as a result of this acquisition.
Global Peripheral Arterial Disease (PAD) Market Scope and Market Size
The peripheral arterial disease (PAD) market is segmented on the basis of treatment type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment Type
- Devices
- Catheters
- Drugs
- Others
On the basis of treatment type, the peripheral arterial disease (PAD) market is segmented into devices, catheters, drugs and other. Drugs can be further sub segmented into lipid-lowering drugs, blood pressure lowering drugs, glucose regulating drugs, blood clot preventing drugs.
Route of Administration
- Oral
- Parenteral
- Others
On the basis of route of administration, the peripheral arterial disease (PAD) market is segmented into oral, parenteral and others.
End Users
- Hospitals
- Specialty Clinics
- Others
On the basis of end users, the peripheral arterial disease (PAD) market is segmented into hospitals, specialty clinics, others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
On the basis of distribution channel, the peripheral arterial disease (PAD) market is segmented into hospital pharmacy, retail pharmacy, others.
Peripheral Arterial Disease (PAD) Market Regional Analysis/Insights
The peripheral arterial disease (PAD) market is analysed and market size insights and trends are provided by country, treatment type, route of administration, end users and distribution channel as referenced above.
The countries covered in the peripheral arterial disease (PAD) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the peripheral arterial disease (PAD) market due to the growing latest technology development. Furthermore, the occurrence of variation of innovative drug molecule to enhance the treatment procedure will further boost the growth of the peripheral arterial disease (PAD) market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the peripheral arterial disease (PAD) market due to the rise in the patient pool. Moreover, the growing investment in healthcare sector is further anticipated to propel the growth of the peripheral arterial disease (PAD) market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The peripheral arterial disease (PAD) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for peripheral arterial disease (PAD) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the peripheral arterial disease (PAD) market. The data is available for historic period 2010-2020.
Competitive Landscape and Peripheral Arterial Disease (PAD) Market Share Analysis
The peripheral arterial disease (PAD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to peripheral arterial disease (PAD) market.
Some of the major players operating in the peripheral arterial disease (PAD) market are:
- Bayer AG (Germany)
- Abbott (US)
- Boston Scientific Corporation (US)
- BIOTRONIK (Germany)
- Cardinal Health (US)
- Terumo Corporation (Japan)
- AngioDynamics (US)
- Koninklijke Philips NV (Netherlands)
- Cook (US)
- Medtronic (Ireland)
- Cardinal Health (US)
- B. Braun Melsungen AG (Germany)
SKU-